Societe de Promotion Pharmaceutique du Maghreb S.A. (CBSE:PRO)

Morocco flag Morocco · Delayed Price · Currency is MAD
1,324.00
+74.00 (5.92%)
At close: Aug 6, 2025
5.92%
Market Cap1.32B
Revenue (ttm)805.52M
Net Income (ttm)56.90M
Shares Out1.00M
EPS (ttm)56.90
PE Ratio23.27
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume75
Average Volume66
Open1,324.00
Previous Close1,250.00
Day's Range1,324.00 - 1,324.00
52-Week Range873.00 - 1,324.00
Beta-0.08
RSI74.61
Earnings DateSep 26, 2025

About CBSE:PRO

Societe de Promotion Pharmaceutique du Maghreb S.A. produces, commercializes, imports, and exports medicines, derma-pharmaceuticals, and cosmetic products in Africa. It subcontracts medicines for national and international laboratories. The company was founded in 1947 and is headquartered in Had-Soualem, Morocco. Societe de Promotion Pharmaceutique du Maghreb S.A. is a subsidiary of Hikma Pharmaceuticals PLC. [Read more]

Industry Pharmaceutical Preparations
Founded 1947
Employees 343
Stock Exchange Casablanca Stock Exchange
Ticker Symbol PRO
Full Company Profile

Financial Performance

In 2023, CBSE:PRO's revenue was 805.52 million, an increase of 14.32% compared to the previous year's 704.64 million. Earnings were 56.90 million, a decrease of -24.42%.

Financial Statements

News

There is no news available yet.